We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFX
4276
XCF Global Inc
SAFX
$180M
$4.99K ﹤0.01%
+3,808
New +$5.55K
BGSF icon
4277
BGSF Inc
BGSF
$59.2M
$4.96K ﹤0.01%
698
+682
+4,263% +$4.43K
CENN icon
4278
Cenntro
CENN
$8.46M
$4.95K ﹤0.01%
141
-93
-40% -$3.2K
NRXS icon
4279
Neuraxis
NRXS
$79.2M
$4.95K ﹤0.01%
1,606
-539
-25% -$1.37K
BCG
4280
Binah Capital Group
BCG
$21.9M
$4.95K ﹤0.01%
2,875
+826
+40% +$1.62K
SINT icon
4281
SiNtx Technologies
SINT
$11.3M
$4.93K ﹤0.01%
1,205
+183
+18% +$649
INHD icon
4282
Inno Holdings
INHD
$29.2M
$4.93K ﹤0.01%
7
-6
-46% -$7.45K
SRG
4283
Seritage Growth Properties
SRG
$135M
$4.92K ﹤0.01%
1,158
-3,113
-73% -$10.9K
ATRA icon
4284
Atara Biotherapeutics
ATRA
$80.6M
$4.9K ﹤0.01%
+342
New +$3.94K
IEP icon
4285
Icahn Enterprises
IEP
$5.39B
$4.9K ﹤0.01%
+582
New +$5.09K
MGLD icon
4286
Marygold Companies
MGLD
$47M
$4.9K ﹤0.01%
4,576
-694
-13% -$627
ONCO icon
4287
Onconetix
ONCO
$3.57M
$4.88K ﹤0.01%
31
+24
+343% +$4.04K
BDSX icon
4288
Biodesix
BDSX
$256M
$4.86K ﹤0.01%
644
-789
-55% -$6.07K
GGB icon
4289
Gerdau
GGB
$9.21B
$4.85K ﹤0.01%
1,566
+280
+22% +$847
MTEX icon
4290
Mannatech
MTEX
$9.46M
$4.84K ﹤0.01%
487
-37
-7% -$320
NEUP
4291
Neuphoria Therapeutics
NEUP
$20.6M
$4.83K ﹤0.01%
+410
New +$3.81K
LNZA icon
4292
LanzaTech
LNZA
$69M
$4.83K ﹤0.01%
197
-326
-62% -$9.36K
SONN
4293
DELISTED
Sonnet BioTherapeutics
SONN
$4.81K ﹤0.01%
1,051
-414
-28% -$1.84K
WATT icon
4294
Energous
WATT
$103M
$4.8K ﹤0.01%
622
+382
+159% +$3.63K
VIVK
4295
Vivakor
VIVK
$959K
$4.8K ﹤0.01%
3
-1
-25% -$3.05K
GRCE
4296
Grace Therapeutics
GRCE
$44.6M
$4.79K ﹤0.01%
1,610
+259
+19% +$812
AIRG icon
4297
Airgain
AIRG
$70M
$4.79K ﹤0.01%
+1,103
New +$4.86K
AWX icon
4298
Avalon Holdings
AWX
$11.2M
$4.78K ﹤0.01%
1,831
-317
-15% -$800
HGBL icon
4299
Heritage Global
HGBL
$37.2M
$4.77K ﹤0.01%
2,871
+1,357
+90% +$2.72K
AIRT icon
4300
Air T
AIRT
$84.8M
$4.74K ﹤0.01%
200
+72
+56% +$1.65K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.